TychoBio IVS: Financial statements 2018
CVR: 37211265
Source: annual report 2018, Danish Business Authority
01/11/2017 – 31/10/2018
TychoBio IVS (CVR 37211265) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -64,798 and a net result of DKK 19,246 compared with DKK -29,974 the year before. Equity in the 2018 report amounted to DKK 15,726. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -64,798
- Profit/Loss
- DKK 19,246
- Equity
- DKK 15,726
- Total Assets
- DKK 15,726
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | -65 t. | 19 t. | 16 t. | - |
| 2017 | 0 | -40 t. | -30 t. | 6 t. | - |
| 2016 | - | 46 t. | 36 t. | 36 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of August 1, 2018, Josephine Schrøder Warming has stepped down as adm. dir. of TychoBio IVS.
As of March 1, 2018, Jacob Iver Steglich-Willert is registered as director of TychoBio IVS.
As of March 1, 2018, Josephine Schrøder Warming is registered as adm. dir. of TychoBio IVS.
TychoBio IVS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -29,974.
As of February 28, 2018, Jacob Iver Steglich-Willert has stepped down as adm. dir. of TychoBio IVS.
As of February 28, 2018, Josephine Schrøder Warming has stepped down as director of TychoBio IVS.
About TychoBio IVS
TychoBio IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2015. The company has been dissolved on 13 April 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -2,388. Equity in the 2020 report amounted to DKK 1,395.